The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

About Inno4Life

Inno4Life has extensive expertise, enabling it to provide innovative solutions for the ever-changing needs of the Life Sciences sector, particularly within the pharmaceutical and biotech industry. These include solutions relating to packaging processes and the track & tracing of pharmaceuticals.On April 16, 2020, Inno4Life was acquired by Dec Group. Terms of the transaction were not disclosed.

Inno4Life Headquarter Location

Druivenstraat 5

Breda, 4816 KB,


+31 763020023

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Inno4Life News

Holland Capital exits Inno4Life to Swiss company Dec Group

Apr 20, 2020

Submitted By Karin Wasteson | 20/04/2020 - 3:46pm Holland Capital has sold its portfolio company Inno4Life, a manufacturer of machines for the pharmaceutical industry, to Dec Group, a Swiss powder handling and process containment equipment provider. Inno4Life’s management will remain actively involved in the company after its acquisition, which will continue to operate under its own name following the deal. Inno4Life is a manufacturer of complex filling and packaging machines for the pharmaceutical industry. The company delivers tailor-made solutions to its customers, which include large pharmaceutical companies. Inno4Life searched for a strong partner to team up with in order to enable further international growth, and found this partner in Dec Group. “Dec’s acquisition provides a major growth opportunity for both our businesses through an enhanced service offering for our clients. We will be best positioned to offer outstanding quality solutions and increased effectiveness as a result of combined action and co-operation,” Johan Klootwijk, co-founder and managing director of Inno4Life, commented on the deal. Jan-Frens van Giessel, healthcare partner at Holland Capital, is also pleased with the acquisition: “Inno4Life has gained a strong position within the pharmaceutical industry. The acquisition by Dec is a logical next step that enables Inno4Life to continue their international expansion.” Focusing on healthcare and tech, and investing 90 percent in Dutch companies, the Amsterdam-based private equity firm has exited more than 140 companies to date. Holland Capital’s previous exits include Dutch Sec, Highcare and Karify.

  • When was Inno4Life founded?

    Inno4Life was founded in 2010.

  • Where is Inno4Life's headquarters?

    Inno4Life's headquarters is located at Druivenstraat 5, Breda.

  • What is Inno4Life's latest funding round?

    Inno4Life's latest funding round is Acquired.

  • Who are the investors of Inno4Life?

    Investors of Inno4Life include Dec Group and Zeeuws InvesteringsFonds.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.